Search details
1.
Adoptive cellular therapy with T cells expressing the dendritic cell growth factor Flt3L drives epitope spreading and antitumor immunity.
Nat Immunol
; 21(8): 914-926, 2020 08.
Article
in English
| MEDLINE | ID: mdl-32424363
2.
IL-15 Preconditioning Augments CAR T Cell Responses to Checkpoint Blockade for Improved Treatment of Solid Tumors.
Mol Ther
; 28(11): 2379-2393, 2020 11 04.
Article
in English
| MEDLINE | ID: mdl-32735774
3.
CRISPR/Cas9 mediated deletion of the adenosine A2A receptor enhances CAR T cell efficacy.
Nat Commun
; 12(1): 3236, 2021 05 28.
Article
in English
| MEDLINE | ID: mdl-34050151
4.
CAR T Cells for Acute Myeloid Leukemia: State of the Art and Future Directions.
Front Oncol
; 10: 697, 2020.
Article
in English
| MEDLINE | ID: mdl-32435621
5.
Macrophage-Derived CXCL9 and CXCL10 Are Required for Antitumor Immune Responses Following Immune Checkpoint Blockade.
Clin Cancer Res
; 26(2): 487-504, 2020 01 15.
Article
in English
| MEDLINE | ID: mdl-31636098
6.
Supercharging adoptive T cell therapy to overcome solid tumor-induced immunosuppression.
Sci Transl Med
; 11(495)2019 06 05.
Article
in English
| MEDLINE | ID: mdl-31167925
7.
Switching on the green light for chimeric antigen receptor T-cell therapy.
Clin Transl Immunology
; 8(5): e1046, 2019.
Article
in English
| MEDLINE | ID: mdl-31073403
8.
Tissue-specific tumor microenvironments influence responses to immunotherapies.
Clin Transl Immunology
; 8(11): e1094, 2019.
Article
in English
| MEDLINE | ID: mdl-31768254
9.
Dual PD-1 and CTLA-4 Checkpoint Blockade Promotes Antitumor Immune Responses through CD4+Foxp3- Cell-Mediated Modulation of CD103+ Dendritic Cells.
Cancer Immunol Res
; 6(9): 1069-1081, 2018 09.
Article
in English
| MEDLINE | ID: mdl-30018045
10.
A Multifunctional Role for Adjuvant Anti-4-1BB Therapy in Augmenting Antitumor Response by Chimeric Antigen Receptor T Cells.
Cancer Res
; 77(6): 1296-1309, 2017 03 15.
Article
in English
| MEDLINE | ID: mdl-28082401
11.
Targeting the adenosine 2A receptor enhances chimeric antigen receptor T cell efficacy.
J Clin Invest
; 127(3): 929-941, 2017 Mar 01.
Article
in English
| MEDLINE | ID: mdl-28165340
12.
Dual-specific Chimeric Antigen Receptor T Cells and an Indirect Vaccine Eradicate a Variety of Large Solid Tumors in an Immunocompetent, Self-antigen Setting.
Clin Cancer Res
; 23(10): 2478-2490, 2017 May 15.
Article
in English
| MEDLINE | ID: mdl-27965307
Results
1 -
12
de 12
1
Next >
>>